Search research articles
Contact Us
Filters
Showing results (11-20 of 75) with videos related to
Page
of 8
Sort By:
Expert Opinion on Pharmacotherapy
|
February 14, 2012
Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies
Sonia Vallet, Mathias Witzens-Harig, Dirk Jaeger, et al.
Pharmaceutics
|
October 26, 2018
Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
Sonia Vallet, Julia-Marie Filzmoser, Martin Pecherstorfer, et al.
Expert Opinion on Therapeutic Targets
|
March 23, 2025
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy
Rajeshwari Meli, Osman Aksoy, Sonia Vallet, et al.
Cytokine
|
November 4, 2022
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Osman Aksoy, Judith Lind, Vincent Sunder-Plaßmann, et al.
Leukemia & Lymphoma
|
May 3, 2008
Thalidomide and lenalidomide: Mechanism-based potential drug combinations
Sonia Vallet, Antonio Palumbo, Noopur Raje, et al.
Expert Opinion on Investigational Drugs
|
April 10, 2019
Targeting transcription factors in multiple myeloma: evolving therapeutic strategies
Shirong Li, Sonia Vallet, Antonio Sacco, et al.
Leukemia & Lymphoma
|
January 19, 2018
A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma
Sonia Vallet, Nicholas R Hoyle, Robert A Kyle, et al.
Expert Opinion on Pharmacotherapy
|
July 13, 2022
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Vincent Sunder-Plassmann, Osman Aksoy, Judith Lind, et al.
Expert Opinion on Emerging Drugs
|
March 3, 2009
Emerging therapies for multiple myeloma
Klaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.
Investigational New Drugs
|
May 20, 2015
In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis
Sarah Schott, Sonia Vallet, Robert J Tower, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 75) with videos related to
Sort By:
Page
of 8
Expert Opinion on Pharmacotherapy
|
February 14, 2012
Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies
Sonia Vallet, Mathias Witzens-Harig, Dirk Jaeger, et al.
Pharmaceutics
|
October 26, 2018
Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
Sonia Vallet, Julia-Marie Filzmoser, Martin Pecherstorfer, et al.
Expert Opinion on Therapeutic Targets
|
March 23, 2025
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy
Rajeshwari Meli, Osman Aksoy, Sonia Vallet, et al.
Cytokine
|
November 4, 2022
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Osman Aksoy, Judith Lind, Vincent Sunder-Plaßmann, et al.
Leukemia & Lymphoma
|
May 3, 2008
Thalidomide and lenalidomide: Mechanism-based potential drug combinations
Sonia Vallet, Antonio Palumbo, Noopur Raje, et al.
Expert Opinion on Investigational Drugs
|
April 10, 2019
Targeting transcription factors in multiple myeloma: evolving therapeutic strategies
Shirong Li, Sonia Vallet, Antonio Sacco, et al.
Leukemia & Lymphoma
|
January 19, 2018
A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma
Sonia Vallet, Nicholas R Hoyle, Robert A Kyle, et al.
Expert Opinion on Pharmacotherapy
|
July 13, 2022
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Vincent Sunder-Plassmann, Osman Aksoy, Judith Lind, et al.
Expert Opinion on Emerging Drugs
|
March 3, 2009
Emerging therapies for multiple myeloma
Klaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.
Investigational New Drugs
|
May 20, 2015
In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis
Sarah Schott, Sonia Vallet, Robert J Tower, et al.
Page
of 8